학술논문
In Reply...Meijer LL, Puik JR, Peters GJ et al. hENT-1 expression and localization predict outcome after adjuvant gemcitabine in resected cholangiocarcinoma patients. Oncologist 2016; 21:e4.
Document Type
Academic Journal
Author
Brandi, Giovanni; Deserti, Marzia; Vasuri, Francesco; Farioli, Andrea; Degiovanni, Alessio; Palloni, Andrea; Frega, Giorgio; Barbera, Maria A.; Lorenzo, Stefania; Garajova, Ingrid; Di Marco, Mariacristina; Pinna, Antonio D.; Cescon, Matteo; Cucchetti, Alessandro; Ercolani, Giorgio; D'Errico‐Grigioni, Antonietta; Pantaleo, Maria A.; Biasco, Guido; Tavolari, Simona; Aprile, Giuseppe; et al
Source
Oxford University Press / USA Dec2016; v.21 n.12, e5-e6. (2p)
Subject
Language
English
ISSN
1083-7159
Abstract
Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine‐based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.